Advanced Biomedical Technologies, Inc.
ABMT · OTC
7/31/2022 | 4/30/2022 | 1/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Revenue | -$5 | -$0 | $281 | $124 |
| % Growth | -4,742.2% | -100% | 127.6% | – |
| Cost of Goods Sold | $2 | $7 | $40 | $33 |
| Gross Profit | -$7 | -$7 | $241 | $91 |
| % Margin | 147.6% | 6,584.3% | 85.6% | 73.4% |
| R&D Expenses | $50 | $40 | $49 | $52 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $50 | $61 | $46 | $120 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $100 | $101 | $95 | $172 |
| Operating Income | -$107 | -$107 | $146 | -$81 |
| % Margin | 2,162.8% | 105,165.7% | 51.9% | -65.7% |
| Other Income/Exp. Net | -$83 | -$83 | -$88 | -$88 |
| Pre-Tax Income | -$190 | -$190 | $58 | -$170 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$190 | -$190 | $58 | -$170 |
| % Margin | 3,842.6% | 186,752.9% | 20.6% | -137.1% |
| EPS | -0.003 | -0.003 | 0.001 | -0.002 |
| % Growth | 0% | -437.5% | 133.3% | – |
| EPS Diluted | -0.003 | -0.003 | 0.001 | -0.002 |
| Weighted Avg Shares Out | 70,685 | 70,660 | 70,605 | 70,605 |
| Weighted Avg Shares Out Dil | 70,685 | 70,660 | 70,765 | 70,605 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $83 | $84 | $83 | $82 |
| Depreciation & Amortization | $3 | $7 | $7 | $7 |
| EBITDA | -$104 | -$100 | $148 | -$81 |
| % Margin | 2,105% | 97,856.9% | 52.4% | -65.8% |